Nifty
:
24080.40
Sensex
:
76957.27
-95.25 (-0.39%)
-307.24 (-0.40%)
Nifty
Sensex
:
:
24080.40
76957.27
-95.25 (-0.39%)
-307.24 (-0.40%)

Healthcare Global Enterprises Ltd.

Hospital & Healthcare Services

Rating :
61/99

BSE: 539787 | NSE: HCG

NSE BSE
696.30
28-Aug-2026
  • Open
  • High
  • Low
  • Previous Close
  •  703.95
  •  704.9
  •  693.55
  •  699.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  54966
  •  38478791.75
  •  799.71
  •  513.3

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 10,386.21
  • 455.94
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 10,755.70
  • N/A
  • 7.71

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 64.21%
  • 1.80%
  • 10.83%
  • FII
  • DII
  • Others
  • 2.73%
  • 16.53%
  • 3.90%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.75
  • 12.72
  • 9.99

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.89
  • 14.32
  • 7.12

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -4.66
  • -23.86
  • -34.15

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 59.57
  • 135.13
  • 148.60

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.01
  • 6.36
  • 7.64

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.94
  • 17.99
  • 18.99

Earnings Forecasts:

(Updated: 29-08-2026)
Description
2026
2027
2028
2029
Adj EPS
52
2
97.61
3.7
P/E Ratio
13.39
348.15
7.13
188.19
Revenue
70.99
44.97
27.75
2561.2
EBITDA
2910.61
3334.86
3889.03
464.9
Net Income
572.9
690.45
814.9
40.34
ROA
138.21
222.84
333.03
-
P/B Ratio
-
-
-
9.52
ROE
6.57
5.77
4.73
4.82
FCFF
8.96
12.86
15.47
191.67
FCFF Yield
191.57
293.81
394.8
1.75
Net Debt
1.75
2.68
3.6
-
BVPS
-
-
-
73.11

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
695.10
613.16
13.36%
652.33
585.16
11.48%
633.07
558.57
13.34%
646.85
553.54
16.86%
Expenses
572.84
505.37
13.35%
527.25
479.44
9.97%
523.46
470.19
11.33%
523.54
451.27
16.01%
EBITDA
122.26
107.79
13.42%
125.08
105.72
18.31%
109.61
88.38
24.02%
123.31
102.27
20.57%
EBIDTM
17.59%
17.58%
19.17%
18.07%
17.31%
15.82%
19.06%
18.48%
Other Income
12.13
6.83
77.60%
13.07
10.23
27.76%
2.47
4.64
-46.77%
2.62
11.13
-76.46%
Interest
39.87
45.47
-12.32%
42.70
44.17
-3.33%
44.78
40.70
10.02%
43.62
35.98
21.23%
Depreciation
70.42
57.91
21.60%
62.81
58.07
8.16%
60.65
56.52
7.31%
62.80
49.74
26.26%
PBT
24.10
11.24
114.41%
0.73
13.71
-94.68%
-6.02
-4.20
-
19.51
27.68
-29.52%
Tax
8.57
5.94
44.28%
-2.79
6.85
-
1.83
-11.05
-
-0.84
6.97
-
PAT
15.53
5.30
193.02%
3.52
6.86
-48.69%
-7.85
6.85
-
20.35
20.71
-1.74%
PATM
2.23%
0.86%
0.54%
1.17%
-1.24%
1.23%
3.15%
3.74%
EPS
0.92
0.34
170.59%
0.15
0.52
-71.15%
-0.66
0.50
-
1.15
1.28
-10.16%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
2,627.35
2,538.43
2,218.14
1,907.87
1,691.41
1,394.78
1,009.18
1,092.34
976.03
828.79
700.11
Net Sales Growth
13.72%
14.44%
16.26%
12.80%
21.27%
38.21%
-7.61%
11.92%
17.77%
18.38%
 
Cost Of Goods Sold
709.23
692.30
580.60
475.42
424.07
354.91
240.31
239.86
218.64
189.72
170.91
Gross Profit
1,918.12
1,846.13
1,637.54
1,432.45
1,267.35
1,039.88
768.87
852.48
757.39
639.07
529.20
GP Margin
73.01%
72.73%
73.82%
75.08%
74.93%
74.56%
76.19%
78.04%
77.60%
77.11%
75.59%
Total Expenditure
2,147.09
2,079.63
1,835.57
1,582.53
1,411.17
1,159.81
886.86
923.46
853.48
716.44
595.12
Power & Fuel Cost
-
43.95
43.97
39.35
36.89
34.54
31.75
33.26
28.82
22.89
16.42
% Of Sales
-
1.73%
1.98%
2.06%
2.18%
2.48%
3.15%
3.04%
2.95%
2.76%
2.35%
Employee Cost
-
378.60
353.48
308.24
275.12
233.65
195.94
208.03
184.52
157.71
121.92
% Of Sales
-
14.91%
15.94%
16.16%
16.27%
16.75%
19.42%
19.04%
18.91%
19.03%
17.41%
Manufacturing Exp.
-
677.79
598.62
520.39
456.89
391.27
316.75
337.65
291.94
229.97
203.61
% Of Sales
-
26.70%
26.99%
27.28%
27.01%
28.05%
31.39%
30.91%
29.91%
27.75%
29.08%
General & Admin Exp.
-
248.46
225.11
204.67
176.67
118.64
85.52
88.17
116.78
99.18
74.46
% Of Sales
-
9.79%
10.15%
10.73%
10.45%
8.51%
8.47%
8.07%
11.96%
11.97%
10.64%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
38.52
33.80
34.47
41.54
26.82
16.58
16.48
12.79
16.99
0.00
% Of Sales
-
1.52%
1.52%
1.81%
2.46%
1.92%
1.64%
1.51%
1.31%
2.05%
1.11%
EBITDA
480.26
458.80
382.57
325.34
280.24
234.97
122.32
168.88
122.55
112.35
104.99
EBITDA Margin
18.28%
18.07%
17.25%
17.05%
16.57%
16.85%
12.12%
15.46%
12.56%
13.56%
15.00%
Other Income
30.29
31.96
39.53
21.19
31.63
15.67
21.20
10.27
10.06
19.28
9.67
Interest
170.97
176.57
154.56
108.74
103.50
97.77
119.17
137.65
69.91
42.35
23.00
Depreciation
256.68
244.17
211.34
174.36
163.47
158.28
159.22
148.44
85.08
71.46
56.83
PBT
38.32
70.03
56.19
63.44
44.90
-5.41
-134.85
-106.94
-22.39
17.81
34.84
Tax
6.77
4.14
8.13
26.39
27.25
48.85
-7.56
6.19
-2.50
10.24
11.80
Tax Rate
17.67%
16.27%
14.47%
39.19%
60.69%
54.76%
3.31%
-5.79%
11.17%
35.83%
33.87%
PAT
31.55
13.75
44.41
48.15
29.35
53.73
-193.46
-106.69
-24.80
20.53
22.17
PAT before Minority Interest
21.07
22.77
48.83
41.33
17.63
38.92
-221.10
-125.45
-30.88
16.94
23.04
Minority Interest
-10.48
-9.02
-4.42
6.82
11.72
14.81
27.64
18.76
6.08
3.59
-0.87
PAT Margin
1.20%
0.54%
2.00%
2.52%
1.74%
3.85%
-19.17%
-9.77%
-2.54%
2.48%
3.17%
PAT Growth
-20.57%
-69.04%
-7.77%
64.05%
-45.38%
-
-
-
-
-7.40%
 
EPS
2.11
0.92
2.97
3.23
1.97
3.60
-12.96
-7.15
-1.66
1.38
1.48

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
1,331.97
922.44
825.78
860.52
870.29
697.18
381.25
476.65
515.10
432.66
Share Capital
149.30
139.42
139.29
139.12
139.01
125.36
88.69
87.92
86.90
85.71
Total Reserves
1,182.67
760.67
668.93
709.38
724.56
521.15
285.51
383.16
394.52
345.73
Non-Current Liabilities
1,455.25
1,481.78
1,091.62
871.01
860.11
822.06
1,231.51
557.18
482.78
354.08
Secured Loans
584.15
587.51
466.36
340.49
348.81
323.17
482.36
376.14
224.38
136.79
Unsecured Loans
15.04
17.08
18.95
21.25
14.07
23.00
47.25
140.77
148.05
146.59
Long Term Provisions
25.26
21.43
15.66
13.19
10.51
8.62
7.28
5.64
5.10
3.05
Current Liabilities
982.71
1,046.42
743.71
570.32
469.74
465.25
575.75
547.31
358.76
365.53
Trade Payables
351.04
334.26
281.06
248.45
193.94
145.52
153.57
152.75
142.47
127.36
Other Current Liabilities
426.36
407.23
335.56
298.85
253.17
241.94
317.31
337.27
204.97
190.21
Short Term Borrowings
178.33
282.93
106.59
3.44
4.82
67.02
93.66
49.99
1.74
41.63
Short Term Provisions
26.98
21.99
20.48
19.58
17.81
10.77
11.21
7.31
9.58
6.33
Total Liabilities
3,848.17
3,518.25
2,700.45
2,310.74
2,213.57
2,001.31
2,227.02
1,626.69
1,420.56
1,209.73
Net Block
2,461.62
2,441.89
1,758.16
1,553.00
1,547.14
1,382.38
1,646.08
970.21
827.72
684.70
Gross Block
3,801.86
3,616.23
2,780.76
2,419.31
2,254.74
1,933.10
2,024.62
1,197.40
970.11
773.36
Accumulated Depreciation
1,340.24
1,174.34
1,022.59
866.31
707.61
550.72
378.55
227.18
142.40
88.66
Non Current Assets
2,747.41
2,674.45
2,020.59
1,730.41
1,711.23
1,566.34
1,923.25
1,353.72
1,200.47
965.55
Capital Work in Progress
18.57
24.76
83.18
18.18
21.73
30.01
46.09
152.63
173.97
148.23
Non Current Investment
13.88
11.31
10.32
9.69
8.82
26.28
34.12
49.05
53.17
3.95
Long Term Loans & Adv.
227.28
165.61
149.70
116.31
99.32
98.89
162.52
128.08
95.50
82.24
Other Non Current Assets
26.07
30.88
19.21
33.22
34.24
28.78
34.44
53.75
50.11
46.44
Current Assets
1,068.49
843.80
679.85
580.34
502.34
434.96
303.79
272.96
220.09
244.18
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
7.49
Inventories
59.82
53.02
42.67
38.29
29.97
21.11
23.26
26.77
24.03
18.77
Sundry Debtors
420.70
400.90
294.03
302.51
217.44
186.60
185.66
156.89
128.44
103.22
Cash & Bank
540.92
347.70
303.07
196.64
197.51
40.85
32.02
20.87
28.80
85.22
Other Current Assets
47.06
14.25
12.82
12.34
57.41
186.40
62.85
68.44
38.83
29.48
Short Term Loans & Adv.
31.75
27.93
27.26
30.56
45.31
172.57
52.08
58.50
31.80
25.05
Net Current Assets
85.78
-202.62
-63.85
10.02
32.59
-30.29
-271.96
-274.35
-138.66
-121.35
Total Assets
3,815.90
3,518.25
2,700.44
2,310.75
2,213.57
2,001.30
2,227.04
1,626.68
1,420.56
1,209.73

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
347.09
317.11
284.58
251.59
220.12
120.52
130.14
98.50
97.81
91.28
PBT
26.91
56.96
67.73
44.88
87.77
-228.66
-119.26
-33.38
27.18
34.84
Adjustment
394.56
368.52
291.41
275.29
166.57
361.93
298.76
166.82
101.82
74.57
Changes in Working Capital
-42.56
-76.50
-27.19
-45.87
-10.52
-50.71
-22.65
2.10
-26.98
-12.06
Cash after chg. in Working capital
378.90
348.99
331.95
274.31
243.83
82.55
156.85
135.55
102.02
97.35
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-31.82
-31.88
-47.37
-22.71
-23.70
37.97
-26.71
-37.05
-4.20
-6.07
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-177.47
-487.75
-225.73
-133.03
124.59
-171.10
-101.38
-238.20
-281.70
-209.80
Net Fixed Assets
-196.26
-119.04
-318.68
-102.32
-95.61
98.63
-387.66
-126.89
-125.69
-48.61
Net Investments
-7.95
-189.43
-31.39
-36.27
-73.00
-49.53
-17.09
-80.20
-77.42
13.27
Others
26.74
-179.28
124.34
5.56
293.20
-220.20
303.37
-31.11
-78.59
-174.46
Cash from Financing Activity
240.68
-42.44
-64.02
-140.07
-154.88
112.24
-58.42
83.51
161.29
89.15
Net Cash Inflow / Outflow
410.29
-213.08
-5.16
-21.51
189.82
61.66
-29.67
-56.18
-22.60
-29.37
Opening Cash & Equivalents
-47.06
166.02
171.18
192.69
2.87
-58.79
-29.12
27.06
51.08
80.45
Closing Cash & Equivalent
363.23
-47.06
166.02
171.18
192.69
2.87
-58.79
-29.12
27.06
51.08

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
89.21
64.16
58.02
60.99
62.12
51.57
42.19
53.58
55.40
50.34
ROA
0.62%
1.57%
1.65%
0.78%
1.85%
-10.46%
-5.87%
-1.31%
1.39%
2.06%
ROE
2.04%
5.72%
4.99%
2.06%
5.16%
-43.32%
-26.77%
-4.18%
4.02%
5.38%
ROCE
9.77%
12.36%
12.79%
11.69%
15.17%
-9.66%
2.75%
4.50%
7.75%
7.22%
Fixed Asset Turnover
0.68
0.69
0.73
0.72
0.67
0.51
0.68
0.90
0.95
1.00
Receivable days
59.07
57.18
57.06
56.10
52.87
67.32
57.23
53.35
51.01
45.03
Inventory Days
8.11
7.87
7.74
7.36
6.68
8.02
8.36
9.50
9.42
8.37
Payable days
180.65
193.42
203.27
190.39
174.56
227.13
233.06
90.28
98.06
102.64
Cash Conversion Cycle
-113.47
-128.37
-138.46
-126.92
-115.01
-151.79
-167.47
-27.43
-37.62
-49.23
Total Debt/Equity
0.68
1.11
0.83
0.47
0.47
0.73
1.91
1.40
0.96
0.97
Interest Cover
1.15
1.37
1.62
1.43
1.90
-0.92
0.22
0.68
1.67
2.52

Annual Reports:

FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Healthcare Global Enterprises to make further investment of Rs 16 crore in HCG Rajkot
    7th Aug 2026, 11:51 AM

    The Board of Directors of the Company, at their meeting held on August 06, 2026, has approved the same

    Read More
  • Healthcare Global - Quarterly Results
    7th Aug 2026, 00:00 AM

    Read More
  • Healthcare Global Enterprises’ arm inks pact to acquire 26% stake in EVRE
    5th Aug 2026, 10:11 AM

    The acquisition is expected to be completed in Q2FY2027

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.